Leaflet ATIMOS 0.012mg / dose pressurized inhalation solution

Product code:
W63349002
Quantity:
1
Indicated for:
asthma; chronic obstructive pulmonary disease
Route of administration:
inhalation
Substance:
formoterol (beta-2 adrenergic agonist)
ATC
R03AC13 — Respiratory system | Adrenergics, inhalants | Selective beta-2-adrenoreceptor agonists

Precautions:

Hyperglycemia

This medicine may increase blood sugar.

Cardiac risk / QT prolongation / arrhythmias

This medicine may increase the risk of heart rhythm disturbances.

Formoterol is a bronchodilator medication used in the treatment of asthma and chronic obstructive pulmonary disease (COPD). It works by relaxing the muscles of the airways, making breathing easier and reducing symptoms such as coughing, wheezing, and shortness of breath.

Formoterol is usually administered by inhalation, using an inhaler or a dry powder device. The dose and frequency are determined by the doctor based on the severity of the disease and the patient's response to treatment. It is important for patients to use the inhalation device correctly to ensure the medication's effectiveness.

Side effects may include tremors, palpitations, headaches, muscle cramps, or throat irritation. In rare cases, allergic reactions or worsening of respiratory symptoms may occur, in which case medical advice is needed.

Formoterol is an essential medication for long-term control of respiratory symptoms, but it should be used according to medical recommendations and not as an emergency treatment for acute asthma or COPD attacks.

General data about ATIMOS 0.012mg / dose

Substance:
formoterol
Date of latest medicines list:
01-06-2026
Product code:
W63349002
Concentration:
0.012mg / dose
Pharmaceutical form:
pressurized inhalation solution
Quantity:
1
Product type:
Generic medicine
Price:
115.58 RON
Prescription status:
P-6L — Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.

Marketing authorisation

Manufacturer:
CHIESI FARMACEUTICI S.P.A. - ITALIA
Holder:
CHIESI PHARMACEUTICALS GMBH - AUSTRIA
Number:
7657/2006/02
Shelf life:
18 months

Pharmaceutical forms available for formoterol

Concentrations available for formoterol

  • 0.012mg
  • 0.012mg/dose
  • 12mcg
  • 12mcg/dose
  • 4.5mcg/dose
  • 6mcg/dose
  • 9mcg/dose

Compensation lists for ATIMOS 0.012mg / dose Chiesi

B - Sublist B with 50% discount from the reference price

Price
115.58 RON
Copayment
57.79 RON
Patient
57.79 RON